Update on Staphylococcus aureus bacteraemia

A Tabah, KB Laupland - Current opinion in critical care, 2022 - journals.lww.com
Our review confirms that Staphylococcus aureus represents a special aetiology among all
causes of bloodstream infections. Pending results of platform and larger trials, its distinct …

Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus …

YS Alsowaida, G Benitez, K Bin Saleh, TA Almangour… - Antibiotics, 2022 - mdpi.com
(1) Background: Ceftriaxone is a potential alternative for the treatment of methicillin-
susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) in acute care and …

Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus …

ZA Yetmar, RB Khodadadi, JR Go… - European Journal of …, 2023 - Springer
Methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia is associated with poor
outcomes. Ceftriaxone offers logistical advantages over other standard therapies, though in …

Heartbreaking decisions: The dogma and uncertainties of antimicrobial therapy in infective endocarditis

JL Adema, A Ahiskali, M Fida, K Mediwala Hornback… - Pathogens, 2023 - mdpi.com
Infective endocarditis (IE) is a rare but increasingly prevalent disease with high morbidity
and mortality, requiring antimicrobials and at times surgical intervention. Through the …

Associated outcomes of different intravenous antibiotics combined with 2% mupirocin ointment in the treatment of pediatric patients with Staphylococcal scalded skin …

C You, Z Wu, M Liao, X Ye, L Li… - Clinical, Cosmetic and …, 2023 - Taylor & Francis
Purpose To compare treatment duration, influencing factors, and costs among intravenous
antibiotic groups combined with 2% mupirocin ointment for treating staphylococcal scalded …

Outcomes of Ceftriaxone Compared With Cefazolin or Nafcillin/Oxacillin for Outpatient Therapy for Methicillin-Sensitive Staphylococcus aureus Bloodstream …

Y Hamad, KB Nickel, MA Olsen… - Open Forum Infectious …, 2024 - academic.oup.com
Background Ceftriaxone is a convenient option for methicillin-sensitive Staphylococcus
aureus (MSSA) outpatient parenteral antimicrobial therapy (OPAT), but population-based …

Retrospective comparison of the effectiveness and safety of ceftriaxone 1 g twice daily versus 2 g once daily for treatment of aspiration pneumonia

H Kato, M Hagihara, Y Morikawa, N Asai, H Mikamo… - Antibiotics, 2022 - mdpi.com
Although a 2 g once daily administration of ceftriaxone remains the standard dosing regimen
for the treatment of aspiration pneumonia, there are no studies to investigate the optimal …

Evaluating the antimicrobial efficacy of ceftriaxone regimens: 1 g twice daily versus 2 g once daily in a murine model of Streptococcus pneumoniae pneumonia

H Kato, M Hagihara, SI Hiramatsu… - JAC-Antimicrobial …, 2024 - academic.oup.com
Background Ceftriaxone is administered in regimens of either 2 g once-daily or 1 g twice-
daily for the treatment of pneumonia caused by Streptococcus pneumoniae. Previous …

Significant Publications on Infectious Diseases Pharmacotherapy in 2022

N Teran, V Buckley, RS Britt… - Journal of …, 2024 - journals.sagepub.com
Purpose: To provide summarization of the most significant infectious diseases (ID)
pharmacotherapy articles published in peer-reviewed literature in 2022. Summary: Members …

Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?

S Di Bella, M Gatti, L Principe - European Journal of Clinical Microbiology …, 2023 - Springer
Sir, We read with great interest the recent manuscript by Yetmar et al. on different outcomes
of ceftriaxone versus antistaphylococcal penicillins or cefazolin for methicillin-susceptible …